Open Access
ARTICLE
CES1 is associated with cisplatin resistance and poor prognosis of head and neck squamous cell carcinoma
1 Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry ofEducation, Nanning, 530000, China
2 Life Sciences Institute, Guangxi Medical University, Nanning, 530000, China
3 Department of Head and Neck Tumor Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530000, China
* Corresponding Authors: ZHENGBO WEI. Email: ; YING XIE. Email: